Verzenios 100 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6 inhibitors. "The EX-AI study"
This study looks at how exercise affects the quality of life for women with early breast cancer. These women are taking hormone treatments, sometimes with another medicine called a CDK4/6 inhibitor. The study wants to see if exercise helps with symptoms and overall well-being.
For: Early Breast CancerSpain - AuthorisedTherapeutic use (Phase IV)
DOSABEMA-Pharmacokinetic model of abemaciclib: correlation with severe diarrhea as the primary toxicity endpoint in patients with hormone receptor-positive localized breast cancer
This study looks at how a breast cancer drug, Verzenios, affects people's bodies and how this links to side effects like severe diarrhoea. It focuses on women with a specific type of breast cancer to understand the drug better and make treatment safer.
For: HER2- breast cancer at high risk of recurrenceFrance - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1 /2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of amcenestrant (SAR439859 ), administered orally as monotherapy, then in combination with other anti-cancer therapies in postmenopausal women with estrogen receptor-positive advanced breast cancer
This study looks at a new drug, amcenestrant, for postmenopausal women with advanced breast cancer. It tests its safety and how well it works, both alone and with other common cancer medicines.
For: CancerBelgium · Spain